You are here
JFDA approves emergency use of Johnson & Johnson’s COVID vaccine
By JT - Mar 01,2021 - Last updated at Mar 01,2021
AMMAN — The Jordan Food and Drug Administration (JFDA) said on Monday that the administration approved the emergency use of the Johnson & Johnson’s COVID-19 vaccine, JFDA Director General Nizar Muhaidat said in a statement carried by the Jordan News Agency, Petra.
Johnson & Johnson’s vaccine is the fourth to be approved by the JFDA, after Pfizer, Sinopharm and AstraZeneca.
Related Articles
AMMAN — The Jordan Food and Drug Administration (JFDA) on Wednesday announced that Russia’s Sputnik COVID-19 vaccine was approved for emerge
AMMAN — The national COVID-19 vaccination programme will kick off on Wednesday morning, Health Minister Nathir Obeidat said on Saturday, not
AMMAN — The AstraZeneca vaccine showed efficacy in reducing hospital admissions and COVID-19 fatalities, the Jordan Food and Drug Administra
Opinion
Nov 20, 2024
- Popular
- Rated
- Commented
Nov 24, 2024
Nov 24, 2024
Newsletter
Get top stories and blog posts emailed to you each day.
